These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 9513735

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Convergent evidence of the contribution of TP53 genetic variation (Pro72Arg) to metabolic activity and white matter volume in the frontal lobe in schizophrenia patients.
    Molina V, Papiol S, Sanz J, Rosa A, Arias B, Fatjó-Vilas M, Calama J, Hernández AI, Bécker J, Fañanás L.
    Neuroimage; 2011 May 01; 56(1):45-51. PubMed ID: 21296169
    [Abstract] [Full Text] [Related]

  • 23. Proton magnetic resonance spectroscopy in school-aged autistic children.
    Vasconcelos MM, Brito AR, Domingues RC, da Cruz LC, Gasparetto EL, Werner J, Gonçalves JP.
    J Neuroimaging; 2008 Jul 01; 18(3):288-95. PubMed ID: 18304036
    [Abstract] [Full Text] [Related]

  • 24. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.
    Gruber S, Pinker K, Riederer F, Chmelík M, Stadlbauer A, Bittsanský M, Mlynárik V, Frey R, Serles W, Bodamer O, Moser E.
    Eur J Radiol; 2008 Nov 01; 68(2):320-7. PubMed ID: 17964104
    [Abstract] [Full Text] [Related]

  • 25. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
    Glodzik-Sobanska L, Slowik A, McHugh P, Sobiecka B, Kozub J, Rich KE, Urbanik A, Szczudlik A.
    Psychiatry Res; 2006 Dec 01; 148(2-3):111-20. PubMed ID: 17088051
    [Abstract] [Full Text] [Related]

  • 26. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.
    Vagnozzi R, Signoretti S, Tavazzi B, Floris R, Ludovici A, Marziali S, Tarascio G, Amorini AM, Di Pietro V, Delfini R, Lazzarino G.
    Neurosurgery; 2008 Jun 01; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995
    [Abstract] [Full Text] [Related]

  • 27. MRI volumetry and proton MR spectroscopy of the brain in Lafora disease.
    Villanueva V, Alvarez-Linera J, Gómez-Garre P, Gutiérrez J, Serratosa JM.
    Epilepsia; 2006 Apr 01; 47(4):788-92. PubMed ID: 16650146
    [Abstract] [Full Text] [Related]

  • 28. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
    Appenzeller S, Li LM, Costallat LT, Cendes F.
    Brain; 2005 Dec 01; 128(Pt 12):2933-40. PubMed ID: 16195241
    [Abstract] [Full Text] [Related]

  • 29. Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder.
    Iranzo A, Santamaria J, Pujol J, Moreno A, Deus J, Tolosa E.
    Sleep; 2002 Dec 01; 25(8):867-70. PubMed ID: 12489892
    [Abstract] [Full Text] [Related]

  • 30. Effect of occupational manganese exposure on the central nervous system of welders: 1H magnetic resonance spectroscopy and MRI findings.
    Kim EA, Cheong HK, Choi DS, Sakong J, Ryoo JW, Park I, Kang DM.
    Neurotoxicology; 2007 Mar 01; 28(2):276-83. PubMed ID: 16824604
    [Abstract] [Full Text] [Related]

  • 31. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.
    Wood SJ, Berger GE, Lambert M, Conus P, Velakoulis D, Stuart GW, Desmond P, McGorry PD, Pantelis C.
    Arch Gen Psychiatry; 2006 Sep 01; 63(9):969-76. PubMed ID: 16952999
    [Abstract] [Full Text] [Related]

  • 32. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia.
    Cecil KM, Lenkinski RE, Gur RE, Gur RC.
    Neuropsychopharmacology; 1999 Feb 01; 20(2):131-40. PubMed ID: 9885793
    [Abstract] [Full Text] [Related]

  • 33. Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia.
    Bertolino A, Callicott JH, Nawroz S, Mattay VS, Duyn JH, Tedeschi G, Frank JA, Weinberger DR.
    Neuropsychopharmacology; 1998 Jan 01; 18(1):1-9. PubMed ID: 9408913
    [Abstract] [Full Text] [Related]

  • 34. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study.
    Bertolino A, Callicott JH, Elman I, Mattay VS, Tedeschi G, Frank JA, Breier A, Weinberger DR.
    Biol Psychiatry; 1998 May 01; 43(9):641-8. PubMed ID: 9582997
    [Abstract] [Full Text] [Related]

  • 35. Neuropsychophysiological study of children at risk for schizophrenia: a preliminary report.
    Hendren RL, Hodde-Vargas J, Yeo RA, Vargas LA, Brooks WM, Ford C.
    J Am Acad Child Adolesc Psychiatry; 1995 Oct 01; 34(10):1284-91. PubMed ID: 7592265
    [Abstract] [Full Text] [Related]

  • 36. Decreased left frontal lobe N-acetylaspartate in schizophrenia.
    Deicken RF, Zhou L, Corwin F, Vinogradov S, Weiner MW.
    Am J Psychiatry; 1997 May 01; 154(5):688-90. PubMed ID: 9137129
    [Abstract] [Full Text] [Related]

  • 37. Proton magnetic resonance spectroscopy of the inferior frontal gyrus and thalamus and its relationship to verbal learning task performance in patients with schizophrenia: a preliminary report.
    Hagino H, Suzuki M, Mori K, Nohara S, Yamashita I, Takahashi T, Kurokawa K, Matsui M, Watanabe N, Seto H, Kurachi M.
    Psychiatry Clin Neurosci; 2002 Oct 01; 56(5):499-507. PubMed ID: 12193238
    [Abstract] [Full Text] [Related]

  • 38. Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia.
    Bustillo JR, Rowland LM, Jung R, Brooks WM, Qualls C, Hammond R, Hart B, Lauriello J.
    Neuropsychopharmacology; 2008 Sep 01; 33(10):2456-66. PubMed ID: 18094668
    [Abstract] [Full Text] [Related]

  • 39. Proton magnetic resonance spectroscopy measures related to short-term symptomatic outcome in chronic schizophrenia.
    Szulc A, Konarzewska B, Galinska-Skok B, Lazarczyk J, Waszkiewicz N, Tarasow E, Milewski R, Walecki J.
    Neurosci Lett; 2013 Jun 28; 547():37-41. PubMed ID: 23665527
    [Abstract] [Full Text] [Related]

  • 40. Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia.
    Strzelecki D, Podgórski M, Kałużyńska O, Gawlik-Kotelnicka O, Stefańczyk L, Kotlicka-Antczak M, Gmitrowicz A, Grzelak P.
    Nutrients; 2015 Oct 22; 7(10):8767-82. PubMed ID: 26506383
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.